Senescence-Associated Loss Of Intestinal Α1,2-Fucose Disrupts A Modifiable Host-Microbiome Homeostasis Axis In People With HIV
Even with effective treatment, many individuals living with HIV continue to face persistent gut health challenges, including an imbalance in their gut microbes and a compromised intestinal barrier. This often results in ongoing inflammation and health issues typically associated with aging.
Recent research has uncovered a crucial mechanism behind these issues: a reduction in a naturally occurring sugar molecule called α1,2-fucose within the intestines. This sugar acts as a vital food source, or “prebiotic,” for beneficial gut bacteria, especially those that produce short-chain fatty acids (SCFAs), which are essential for maintaining a healthy gut lining.
The study revealed that this decline in α1,2-fucose is linked to an increase in an enzyme that breaks it down. Consequently, there’s a decrease in SCFA-producing bacteria, which are critical for gut integrity and reducing inflammation. This imbalance contributes to heightened inflammation and signs of premature aging observed in people with HIV.
Encouragingly, the research demonstrated that supplementing with a fucose-like compound, similar to a component found in human milk, could restore the production of these beneficial SCFAs and enhance the gut’s resilience to stress. This discovery highlights a potentially modifiable target, suggesting that interventions aimed at restoring intestinal α1,2-fucose levels could offer a new strategy to improve gut health, reduce chronic inflammation, and potentially mitigate accelerated aging in people with HIV.
Source: link to paper